Gilead Sciences values its sales at £4.31 billion in the fiscal third quarter

Gilead Sciences Inc. (NASDAQ: GILD) said on Wednesday that its profit and sales came in better than expected in the fiscal third quarter. The company, however, lowered its sales guidance for the full year. Shares of the company plunged close to 1.5% in after-hours trading on Wednesday. Including the price action, Gilead Sciences now has a per-share price of £44.59 versus £50.24 per share at the start of the year. Interest in investing in the stock market online? Here’s a simple guide to get you started. Gilead’s Q3 financial results versus analysts’ estimates Gilead said that its net income in